Addex Therapeutics Ltd (SWX:ADXN)
Switzerland · Delayed Price · Currency is CHF 0.0498
-0.0002 (-0.40%)
At close: Jan 30, 2026
Addex Therapeutics Market Cap
Addex Therapeutics has a market cap or net worth of 5.81 million as of January 30, 2026. Its market cap has decreased by -3.53% in one year.
Market Cap
5.81M
Enterprise Value
3.65M
Revenue
158.54K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.05
Market Cap Chart
Since May 22, 2007, Addex Therapeutics's market cap has decreased from 398.65M to 5.81M, a decrease of -98.54%. That is a compound annual growth rate of -20.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 5.83M | -9.75% |
| Dec 30, 2025 | 6.46M | 14.83% |
| Dec 30, 2024 | 5.62M | -9.01% |
| Dec 29, 2023 | 6.18M | -40.48% |
| Dec 30, 2022 | 10.39M | -73.65% |
| Dec 30, 2021 | 39.42M | -25.96% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Idorsia | 906.41M |
| Basilea Pharmaceutica AG | 674.62M |
| Newron Pharmaceuticals | 405.30M |
| Santhera Pharmaceuticals Holding AG | 177.93M |
| BioVersys AG | 140.94M |
| Xlife Sciences AG | 127.46M |
| Molecular Partners AG | 120.61M |
| EvoNext Holdings | 5.91M |